These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 8343513)

  • 1. Importance of main-chain flexibility and the insulin fold in insulin-receptor interactions.
    Nakagawa SH; Tager HS
    Biochemistry; 1993 Jul; 32(28):7237-43. PubMed ID: 8343513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implications of replacing peptide bonds in the COOH-terminal B chain domain of insulin by the psi (CH2-NH) linker.
    Nakagawa SH; Johansen NL; Madsen K; Schwartz TW; Tager HS
    Int J Pept Protein Res; 1993 Dec; 42(6):578-84. PubMed ID: 8307689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of the C-terminus of the insulin B-chain in modulating structural and functional properties of the hormone.
    Leyer S; Gattner HG; Leithäuser M; Brandenburg D; Wollmer A; Höcker H
    Int J Pept Protein Res; 1995 Nov; 46(5):397-407. PubMed ID: 8567184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the phenylalanine B25 side chain in directing insulin interaction with its receptor. Steric and conformational effects.
    Nakagawa SH; Tager HS
    J Biol Chem; 1986 Jun; 261(16):7332-41. PubMed ID: 3519607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disposition of the phenylalanine B25 side chain during insulin-receptor and insulin-insulin interactions.
    Mirmira RG; Tager HS
    Biochemistry; 1991 Aug; 30(33):8222-9. PubMed ID: 1868095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Importance of aliphatic side-chain structure at positions 2 and 3 of the insulin A chain in insulin-receptor interactions.
    Nakagawa SH; Tager HS
    Biochemistry; 1992 Mar; 31(12):3204-14. PubMed ID: 1554705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maintenance of the B-chain beta-turn in [GlyB24] insulin mutants: a steady-state fluorescence anisotropy study.
    Pittman I; Nakagawa SH; Tager HS; Steiner DF
    Biochemistry; 1997 Mar; 36(12):3430-7. PubMed ID: 9131992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Semisynthetic des-(B27-B30)-insulins with modified B26-tyrosine.
    Lenz V; Gattner HG; Sievert D; Wollmer A; Engels M; Höcker H
    Biol Chem Hoppe Seyler; 1991 Jul; 372(7):495-504. PubMed ID: 1930732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Semisynthetic insulin analogues modified in positions B24, B25 and B29.
    Svoboda I; Brandenburg D; Barth T; Gattner HG; Jirácek J; Velek J; Bláha I; Ubik K; Kasicka V; Pospísek J
    Biol Chem Hoppe Seyler; 1994 Jun; 375(6):373-8. PubMed ID: 7980868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-function relationships of des-(B26-B30)-insulin.
    Spoden M; Gattner HG; Zahn H; Brandenburg D
    Int J Pept Protein Res; 1995; 46(3-4):221-7. PubMed ID: 8537175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the COOH-terminal B-chain domain in insulin-receptor interactions. Identification of perturbations involving the insulin mainchain.
    Nakagawa SH; Tager HS
    J Biol Chem; 1987 Sep; 262(25):12054-8. PubMed ID: 3305501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A structural switch in a mutant insulin exposes key residues for receptor binding.
    Ludvigsen S; Olsen HB; Kaarsholm NC
    J Mol Biol; 1998 May; 279(1):1-7. PubMed ID: 9636695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chiral mutagenesis of insulin. Foldability and function are inversely regulated by a stereospecific switch in the B chain.
    Nakagawa SH; Zhao M; Hua QX; Hu SQ; Wan ZL; Jia W; Weiss MA
    Biochemistry; 2005 Apr; 44(13):4984-99. PubMed ID: 15794637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shortened insulin analogues: marked changes in biological activity resulting from replacement of TyrB26 and N-methylation of peptide bonds in the C-terminus of the B-chain.
    Záková L; Barth T; Jirácek J; Barthová J; Zórad S
    Biochemistry; 2004 Mar; 43(8):2323-31. PubMed ID: 14979729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the phenylalanine B24 side chain in directing insulin interaction with its receptor. Importance of main chain conformation.
    Mirmira RG; Tager HS
    J Biol Chem; 1989 Apr; 264(11):6349-54. PubMed ID: 2649499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonlocal structural perturbations in a mutant human insulin: sequential resonance assignment and 13C-isotope-aided 2D-NMR studies of [PheB24-->Gly]insulin with implications for receptor recognition.
    Hua QX; Shoelson SE; Weiss MA
    Biochemistry; 1992 Dec; 31(47):11940-51. PubMed ID: 1445924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutational analysis of invariant valine B12 in insulin: implications for receptor binding.
    Nakagawa SH; Tager HS; Steiner DF
    Biochemistry; 2000 Dec; 39(51):15826-35. PubMed ID: 11123908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations at the dimer, hexamer, and receptor-binding surfaces of insulin independently affect insulin-insulin and insulin-receptor interactions.
    Shoelson SE; Lu ZX; Parlautan L; Lynch CS; Weiss MA
    Biochemistry; 1992 Feb; 31(6):1757-67. PubMed ID: 1737029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Importance of the character and configuration of residues B24, B25, and B26 in insulin-receptor interactions.
    Mirmira RG; Nakagawa SH; Tager HS
    J Biol Chem; 1991 Jan; 266(3):1428-36. PubMed ID: 1988428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A spectroscopic investigation of the conformational dynamics of insulin in solution.
    Pittman I; Tager HS
    Biochemistry; 1995 Aug; 34(33):10578-90. PubMed ID: 7654714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.